Results 221 to 230 of about 9,765 (234)

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Lancet, The, 2012
Michael R Zile, Adriaan A Voors, Milton Packer   +2 more
exaly  

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Nature Reviews Drug Discovery, 2006
Brian Schwartz
exaly  

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Lancet, The, 2013
Marina Cuchel, Dirk J Blom, A David Marais   +2 more
exaly  

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2010
Frederick J Raal, Santos Rd, Santos R, Dirk J Blom   +2 more
exaly  

Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors

Journal of Hepatology, 2016
P. Halfon, C. Scholtès, S. Mohamed, G. Penaranda, V. Leroy, M. Bourlière, D. Ouzan, L. Polverel, M.-A. Thélu, F. Zoulim, H. Khiri, S. Larrat   +11 more
openaire   +1 more source

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Lancet, The, 2007
Jayesh Desai, Suzanne George, Thomas Force   +2 more
exaly  

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Cancer Cell, 2011
Wei Xu, Hui Yang, Ping Wang
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly